Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-30 @ 6:37 PM
Study NCT ID:
NCT04442269
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2020-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-04
First Submit QC Date:
None
Study First Post Date:
2020-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-25
Results First Submit QC Date:
None
Results First Post Date:
2024-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-02
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL